Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms—A Preliminary Study

Neuroendocrine neoplasms (NENs) constitute a heterogenous group of tumors originating from neuroendocrine cells scattered throughout the body. Peptide Receptor Radionuclide Therapy (PRRT) is a treatment of choice of unresectable metastasized progressive and well-differentiated NENs. The aim of the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bober, Barbara, Saracyn, Marek, Zaręba, Kornelia, Lubas, Arkadiusz, Mazurkiewicz, Paweł, Wilińska, Ewelina, Kamiński, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874379/
https://www.ncbi.nlm.nih.gov/pubmed/35207193
http://dx.doi.org/10.3390/jcm11040919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874379/
https://www.ncbi.nlm.nih.gov/pubmed/35207193
http://dx.doi.org/10.3390/jcm11040919

Ejemplares similares